Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04281784 · ClinicalTrials.gov registry record · NA

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

A NA study of Dementia and Pulmonary Disease, Chronic Obstructive, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
2,512
Enrollment target
3
Study locations

NCT04281784: Completed NA study of Dementia and Pulmonary Disease, Chronic Obstructive, sponsored by University of Washington.

NCT04281784 is a NA study of Dementia and Pulmonary Disease, Chronic Obstructive that has completed, run by University of Washington. The registered enrollment target is 2,512 participants, below the 7,710-participant average among 199 other Dementia trials with a reported enrollment target (67% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04281784, a NA study of Dementia and Pulmonary Disease, Chronic Obstructive, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
2,512 participants
Enrollment target
3
Study locations

Study Summary

The objective of this protocol is to test the effectiveness of a Jumpstart intervention on patient-centered outcomes for patients with chronic illness by ensuring that they receive care that is concordant with their goals over time, and across settings and providers. This study will examine the effect of the EHR-based intervention to improve quality of palliative care for patients 55 years or older with chronic, life-limiting illness with a particular emphasis on Alzheimer's disease and related dementias (ADRD). The specific aims are: 1. To evaluate the effectiveness of a novel EHR-based (electronic health record) clinician Jumpstart guide, compared with usual care, for improving the quality of care; the primary outcome is documentation of a goals-of-care discussion in the period between randomization and 30 days following randomization. Secondary outcomes focus on intensity of care: ICU use, ICU and hospital length of stay, costs of care during the hospitalization, and 7 and 30-day hospital readmissions. 2. To conduct a mixed-methods evaluation of the implementation of the intervention, guided by the RE-AIM framework for implementation science, incorporating quantitative evaluation of the intervention's reach and adoption, as well as qualitative analyses of interviews with participants, to explore barriers and facilitators to future implementation and dissemination.

Primary Outcome

The primary outcome is the proportion of patients who have a goals-of-care (GOC) discussion that has been documented in the EHR in the period between randomization and 30 days following randomization The proportion is the number of patients with GOC documentation over the number of patients in each study arm. Documentation of goals-of-care discussions will be evaluated using our NLP/ML methods.

Conditions Studied

Dementia Pulmonary Disease, Chronic Obstructive Chronic Disease Neoplasm Metastasis Heart Failure, Congestive Peripheral Vascular Disease Kidney Failure, Chronic Liver Cirrhosis Lung Diseases, Interstitial Lung Neoplasm

Interventions

  • BEHAVIORAL EHR-based Clinician Jumpstart

Study Locations (3)

Washington

  • Harborview Medical Center - Seattle
  • UW Medical Center - Northwest - Seattle
  • UW Medical Center - Montlake (UWMC) - Seattle

Trial Details

FieldValue
Enrollment Target 2,512 participants
Start Date 2020-04-23
Est. Completion 2022-09-26
Phase NA
University of Washington

1,048 total trials

What the finished NCT04281784 record still lists

NCT04281784 is an interventional study that assigns participants to a tested intervention. Its 2,512 participants enrollment target places it among the larger protocols in the corpus, below the 7,710-participant average among 199 other Dementia trials with a reported enrollment target (67% lower).

The record links to 10 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which EHR-based Clinician Jumpstart is the first listed.

NCT04281784 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT04281784 about?

NCT04281784 is a clinical study titled "Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)". The objective of this protocol is to test the effectiveness of a Jumpstart intervention on patient-centered outcomes for patients with chronic illness by ensuring that they receive care that is concordant with their goals over time, and across settings and providers. This study will examine the effe...

What is the current status of trial NCT04281784?

This trial is currently completed. It is a NA study. The enrollment target is 2,512 participants. The study started on 2020-04-23. Estimated completion is 2022-09-26.

What conditions does trial NCT04281784 study?

This clinical trial studies the following conditions: Dementia, Pulmonary Disease, Chronic Obstructive, Chronic Disease, Neoplasm Metastasis, Heart Failure, Congestive.

What interventions are being tested in trial NCT04281784?

The interventions under investigation include: EHR-based Clinician Jumpstart (BEHAVIORAL).

Who is sponsoring clinical trial NCT04281784?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04281784 being conducted?

This trial has 3 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04281784's enrollment target sits among peer trials

2,512 21st of 199 higher than 179 of 199 other Dementia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001160 · 2,500 participants

    Studies on Tumors of the Thyroid

  • NCT01904188 · 2,500 participants

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

  • NCT02257229 · 2,500 participants

    Prospective Evaluation of Treatment for Clubfoot

  • NCT02530658 · 2,500 participants

    Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04281784, the US trial registry maintained by the National Library of Medicine. NCT04281784 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.